| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phio Pharmaceuticals Corp. (PHIO) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. PHIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 411.4K | $534.8K | - | |
| CFO | 94.0K | $122.2K | - | |
| Dir | 45.7K | $59.3K | - | |
| Dir | 38.7K | $50.3K | - | |
| Dir | 37.8K | $49.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Bitterman Robert J | Chairman, Pres. &CEO | Buy | 5,000 | $1.03 | $5,150.00 | +1.7% | |
| Dec 23, 2025 | Bitterman Robert J | Chairman, Pres. &CEO | Buy | 5,000 | $1.02 | $5,100.00 | +1.8% | |
| Nov 21, 2025 | Bitterman Robert J | Chairman, Pres. &CEO | Buy | 5,000 | $1.14 | $5,700.00 | +1.8% | |
| Nov 18, 2025 | Bitterman Robert J | Chairman, Pres. &CEO | Buy | 5,000 | $1.27 | $6,350.00 | +1.8% | |
| Jun 10, 2025 | Ferrara Robert L | Director | Buy | 2,500 | $2.42 | $6,049.75 | +19.0% | |
| Jun 10, 2025 | Bitterman Robert J | Chairman, Pres &CEO | Buy | 2,000 | $2.42 | $4,840.00 | +8.0% | |
| Jun 9, 2025 | Bitterman Robert J | Chairman, Pres &CEO | Buy | 1,500 | $2.75 | $4,125.00 | +6.3% | |
| May 22, 2025 | Bitterman Robert J | Chairman, Pres &CEO | Buy | 4,200 | $1.77 | $7,445.88 | +10.0% | |
| May 20, 2025 | Ferrara Robert L | Director | Buy | 2,500 | $1.82 | $4,550.00 | +23.4% | |
| Jun 7, 2024 | Bitterman Robert J | President &CEO | Buy | 1,000 | $0.74 | $740.00 | +5.0% |